Cubist Systematic Strategies’s Apellis Pharmaceuticals APLS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-191,687
| Closed | -$6.12M | – | 1449 |
|
|
2024
Q4 | $6.12M | Buy |
+191,687
| New | +$6.12M | 0.04% | 297 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 1470 |
|
|
2024
Q2 | – | Sell |
-36,994
| Closed | -$2.17M | – | 1461 |
|
|
2024
Q1 | $2.17M | Buy |
36,994
+15,464
| +72% | +$909K | 0.01% | 845 |
|
|
2023
Q4 | $1.29M | Sell |
21,530
-21,391
| -50% | -$1.28M | 0.01% | 994 |
|
|
2023
Q3 | $1.63M | Buy |
42,921
+1,742
| +4% | +$66.3K | 0.01% | 858 |
|
|
2023
Q2 | $3.75M | Buy |
41,179
+20,710
| +101% | +$1.89M | 0.02% | 604 |
|
|
2023
Q1 | $1.35M | Buy |
+20,469
| New | +$1.35M | 0.01% | 1318 |
|
|
2022
Q4 | – | Sell |
-13,951
| Closed | -$953K | – | 3250 |
|
|
2022
Q3 | $953K | Buy |
+13,951
| New | +$953K | 0.01% | 2101 |
|
|
2022
Q2 | – | Sell |
-10,304
| Closed | -$524K | – | 3807 |
|
|
2022
Q1 | $524K | Sell |
10,304
-15,993
| -61% | -$813K | ﹤0.01% | 2484 |
|
|
2021
Q4 | $1.24M | Sell |
26,297
-7,549
| -22% | -$357K | 0.01% | 1753 |
|
|
2021
Q3 | $1.12M | Buy |
33,846
+27,262
| +414% | +$899K | 0.01% | 1433 |
|
|
2021
Q2 | $416K | Sell |
6,584
-14,847
| -69% | -$938K | ﹤0.01% | 2125 |
|
|
2021
Q1 | $920K | Buy |
21,431
+12,489
| +140% | +$536K | 0.01% | 1592 |
|
|
2020
Q4 | $511K | Sell |
8,942
-20,266
| -69% | -$1.16M | 0.01% | 1764 |
|
|
2020
Q3 | $881K | Sell |
29,208
-7,513
| -20% | -$227K | 0.01% | 1406 |
|
|
2020
Q2 | $1.2M | Buy |
36,721
+10,597
| +41% | +$346K | 0.02% | 1076 |
|
|
2020
Q1 | $700K | Sell |
26,124
-22,205
| -46% | -$595K | 0.02% | 1046 |
|
|
2019
Q4 | $1.48M | Buy |
48,329
+29,795
| +161% | +$912K | 0.03% | 919 |
|
|
2019
Q3 | $446K | Buy |
18,534
+18,449
| +21,705% | +$444K | 0.01% | 1350 |
|
|
2019
Q2 | $2K | Sell |
85
-12,518
| -99% | -$295K | ﹤0.01% | 2422 |
|
|
2019
Q1 | $246K | Sell |
12,603
-10,748
| -46% | -$210K | 0.01% | 1634 |
|
|
2018
Q4 | $308K | Buy |
+23,351
| New | +$308K | 0.01% | 1262 |
|